To assess the role of FGF21 and FGF23 in patients with endometrial cancer diagnostics, determining whether their concentration correlates with the degree of clinical stage and histopathological differentiation in endometrial cancer patients. The gene discussed is FGF23; the disease is endometrial cancer.